CAS NO: | 1245916-14-6 |
包装: | 1mg |
市场价: | 7020元 |
Cas No. | 1245916-14-6 |
别名 | 阿利库单抗,REGN 727(anti-PCSK9); SAR 236553(anti-PCSK9) |
储存条件 | Store at 4℃, Do not freeze |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
产品描述 | Alirocumab (anti-PCSK9) is a human monoclonal antibody inhibiting proprotein convertase subtilisin/kexin type 9 (PCSK9). Alirocumab specifically binds PCSK9, a down regulator of liver low-density lipoprotein (LDL)-receptors, thereby increasing the ability of the liver to bind LDL-cholesterol (LDL-C) and reducing levels of LDL-C in blood. Alirocumab can be used for the research of hypercholesterolemia[1][2]. [1]. Markham A. Alirocumab: First Global Approval. Drugs. 2015;75(14):1699-1705. |